Pathological diagnosis of general rules for the description of thyroid cancer by Japanese Society of Thyroid Pathology and Japan Association of Endocrine Surgery
-
- Kamma Hiroshi
- Department of Pathology, Kyorin University, Tokyo 181-8611, Japan
-
- Kameyama Kaori
- Department of Pathology, Showa University Northern Yokohama Hospital, Yokohama 224-8503, Japan
-
- Kondo Tetsuo
- Department of Human Pathology, University of Yamanashi, Yamanashi 409-3898, Japan
-
- Imamura Yoshiaki
- Division of Diagnostic Pathology/Surgical Pathology, University of Fukui Hospital, Fukui 910-1193, Japan
-
- Nakashima Masahiro
- Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki 852-8523, Japan
-
- Chiba Tomohiro
- Division of Pathology, the Cancer Institute, Japan Foundation for Cancer Research, Tokyo 135-8550, Japan
-
- Hirokawa Mitsuyoshi
- Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe 650-0011, Japan
この論文をさがす
抄録
<p>The Japanese Society of Thyroid Pathology and the Japan Association of Endocrine Surgeons developed the eighth edition of the General Rules for the Description of Thyroid Cancer (GRDTC) in December 2019. This article describes the pathological diagnosis of the GRDTC, which has been improved through repeated revisions based on the experience of Japanese pathologists and translated into English to introduce the Japanese diagnostic standard to foreign countries. In this edition of the GRDTC, the histopathological classification and descriptions differ in some respects from those of the fourth edition of the World Health Organization (WHO) classification as revised in 2017. For example, the GRDTC does not adopt the concept of borderline lesions (FT-UMP, WDT-UMP, and NIFTP) of the WHO, taking into consideration the popular histological criteria accepted by Japanese pathologists. The cytological reporting system of the GRDTC was partly modified from the Bethesda system in 2015. It has an additional cyst fluid category separated from the unsatisfactory category that has been demonstrated to be useful in Japan. This translated edition makes it easy to submit Japanese clinicopathological studies of thyroid tumors in an international journal. We also wish to contribute to the improvement, standardization, and globalization of the pathological diagnosis of thyroid tumors.</p>
収録刊行物
-
- Endocrine Journal
-
Endocrine Journal 69 (2), 139-154, 2022
一般社団法人 日本内分泌学会
